PulManage, Inc. has identified a substantial market opportunity in respiratory care, with a global addressable market (TAM) of $300 billion. The company aims to tackle various challenges in respiratory care, including accurate diagnosis, disease management, and access to real-time data trends for decentralized clinical trial data collection. Through its patented technology platform, PulManage is pioneering a new approach to support clinical trials and care delivery by enabling remote collection and analysis of respiratory biomarkers from the comfort of home.

PulManage, Inc

Org chart

Teams

Offices